Table of Contents
Metal-Based Drugs
Volume 2010, Article ID 317581, 9 pages
http://dx.doi.org/10.1155/2010/317581
Review Article

Regulation of Cisplatin Cytotoxicity by Cu Influx Transporters

Moores Cancer Center and Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA

Received 9 August 2010; Accepted 7 December 2010

Academic Editor: Giovanni Natile

Copyright © 2010 Paolo Abada and Stephen B. Howell. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Hall, M. Okabe, D. W. Shen, X. J. Liang, and M. M. Gottesman, “The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy,” Annual Review of Pharmacology and Toxicology, vol. 48, pp. 495–535, 2008. View at Publisher · View at Google Scholar · View at PubMed
  2. L. Kelland, “The resurgence of platinum-based cancer chemotherapy,” Nature Reviews Cancer, vol. 7, no. 8, pp. 573–584, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. S. Puig and D. J. Thiele, “Molecular mechanisms of copper uptake and distribution,” Current Opinion in Chemical Biology, vol. 6, no. 2, pp. 171–180, 2002. View at Publisher · View at Google Scholar
  4. M. C. Linder and M. Hazegh-Azam, “Copper biochemistry and molecular biology,” American Journal of Clinical Nutrition, vol. 63, no. 5, pp. 797S–811S, 1996. View at Google Scholar
  5. A. Dancis, D. Haile, D. S. Yuan, and R. D. Klausner, “The Saccharomyces cerevisiae copper transport protein (Ctr1p). Biochemical characterization, regulation by copper, and physiologic role in copper uptake,” Journal of Biological Chemistry, vol. 269, no. 41, pp. 25660–25667, 1994. View at Google Scholar
  6. B. Zhou and J. Gitschier, “hCTR1: a human gene for copper uptake identified by complementation in yeast,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 14, pp. 7481–7486, 1997. View at Publisher · View at Google Scholar
  7. J. Lee, M. M. O. Peña, Y. Nose, and D. J. Thiele, “Biochemical characterization of the human copper transporter Ctr1,” Journal of Biological Chemistry, vol. 277, no. 6, pp. 4380–4387, 2002. View at Publisher · View at Google Scholar · View at PubMed
  8. J. Bertinato, E. Swist, L. J. Plouffe, S. P. J. Brooks, and M. R. L'Abbé, “Ctr2 is partially localized to the plasma membrane and stimulates copper uptake in COS-7 cells,” Biochemical Journal, vol. 409, no. 3, pp. 731–740, 2008. View at Publisher · View at Google Scholar · View at PubMed
  9. E. M. Rees, J. Lee, and D. J. Thiele, “Mobilization of intracellular copper stores by the Ctr2 vacuolar copper transporter,” Journal of Biological Chemistry, vol. 279, no. 52, pp. 54221–54229, 2004. View at Publisher · View at Google Scholar · View at PubMed
  10. M. E. Portnoy, P. J. Schmidt, R. S. Rogers, and V. C. Culotta, “Metal transporters that contribute copper to metallochaperones in Saccharomyces cerevisiae,” Molecular Genetics and Genomics, vol. 265, no. 5, pp. 873–882, 2001. View at Publisher · View at Google Scholar
  11. S. Itoh, W. K. Ha, and W. K. Ha, “Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation,” Journal of Biological Chemistry, vol. 283, no. 14, pp. 9157–9167, 2008. View at Publisher · View at Google Scholar · View at PubMed
  12. M. Greenough, L. Pase, I. Voskoboinik, M. J. Petris, A. W. O'Brien, and J. Camakaris, “Signals regulating trafficking of Menkes (MNK; ATP7A) copper-translocating P-type ATPase in polarized MDCK cells,” American Journal of Physiology, vol. 287, no. 5, pp. C1463–C1471, 2004. View at Publisher · View at Google Scholar · View at PubMed
  13. M. Schaefer, R. G. Hopkins, M. L. Failla, and J. D. Gitlin, “Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver,” American Journal of Physiology, vol. 276, no. 3, pp. G639–G646, 1999. View at Google Scholar
  14. S. Lutsenko, A. Gupta, J. L. Burkhead, and V. Zuzel, “Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance,” Archives of Biochemistry and Biophysics, vol. 476, no. 1, pp. 22–32, 2008. View at Publisher · View at Google Scholar · View at PubMed
  15. L. Banci, I. Bertini, S. Ciofi-Baffoni, T. Kozyreva, K. Zovo, and P. Palumaa, “Affinity gradients drive copper to cellular destinations,” Nature, vol. 465, no. 7298, pp. 645–648, 2010. View at Publisher · View at Google Scholar · View at PubMed
  16. J. Lee, J. R. Prohaska, S. L. Dagenais, T. W. Glover, and D. J. Thiele, “Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutant,” Gene, vol. 254, no. 1-2, pp. 87–96, 2000. View at Publisher · View at Google Scholar
  17. C. J. De Feo, S. G. Aller, G. S. Siluvai, N. J. Blackburn, and V. M. Unger, “Three-dimensional structure of the human copper transporter hCTR1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 11, pp. 4237–4242, 2009. View at Publisher · View at Google Scholar · View at PubMed
  18. M. Schushan, Y. Barkan, T. Haliloglu, and N. Ben-Tal, “Cα-trace model of the transmembrane domain of human copper transporter 1, motion and functional implications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 24, pp. 10908–10913, 2010. View at Publisher · View at Google Scholar · View at PubMed
  19. P. Naredi, D. D. Heath, R. E. Enns, and S. B. Howell, “Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells,” Journal of Clinical Investigation, vol. 95, no. 3, pp. 1193–1198, 1995. View at Google Scholar
  20. P. Naredi, D. D. Heath, R. E. Enns, and S. B. Howell, “Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line,” Cancer Research, vol. 54, no. 24, pp. 6464–6468, 1994. View at Google Scholar
  21. R. Safaei and S. B. Howell, “Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs,” Critical Reviews in Oncology/Hematology, vol. 53, no. 1, pp. 13–23, 2005. View at Publisher · View at Google Scholar · View at PubMed
  22. K. Katano, A. Kondo, and A. Kondo, “Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper,” Cancer Research, vol. 62, no. 22, pp. 6559–6565, 2002. View at Google Scholar
  23. R. Safaei, K. Katano, G. Samimi, W. Naerdemann, J. L. Stevenson, M. Rochdi, and S. B. Howell, “Cross-resistance to cisplatin in cells with acquired resistance to copper,” Cancer Chemotherapy and Pharmacology, vol. 53, no. 3, pp. 239–246, 2004. View at Publisher · View at Google Scholar · View at PubMed
  24. S. Ishida, J. Lee, D. J. Thiele, and I. Herskowitz, “Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 22, pp. 14298–14302, 2002. View at Publisher · View at Google Scholar · View at PubMed
  25. B. G. Blair, C. Larson, R. Safaei, and S. B. Howell, “Copper transporter 2 regulates the cellular accumulation and cytotoxicity of cisplatin and carboplatin,” Clinical Cancer Research, vol. 15, no. 13, pp. 4312–4321, 2009. View at Publisher · View at Google Scholar · View at PubMed
  26. C. A. Larson, B. G. Blair, R. Safaei, and S. B. Howell, “The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs,” Molecular Pharmacology, vol. 75, no. 2, pp. 324–330, 2009. View at Publisher · View at Google Scholar · View at PubMed
  27. F. Arnesano, S. Scintilla, and G. Natile, “Interaction between platinum complexes and a methionine motif found in copper transport proteins,” Angewandte Chemie, vol. 46, no. 47, pp. 9062–9064, 2007. View at Publisher · View at Google Scholar · View at PubMed
  28. C. M. Sze, G. N. Khairallah, Z. Xiao, P. S. Donnelly, R. A. J. O'Hair, and A. G. Wedd, “Interaction of cisplatin and analogues with a Met-rich protein site,” Journal of Biological Inorganic Chemistry, vol. 14, no. 2, pp. 163–165, 2009. View at Publisher · View at Google Scholar · View at PubMed
  29. A. K. Boal and A. C. Rosenzweig, “Crystal structures of cisplatin bound to a human copper chaperone,” Journal of the American Chemical Society, vol. 131, no. 40, pp. 14196–14197, 2009. View at Publisher · View at Google Scholar · View at PubMed
  30. S. B. Howell, R. Safaei, C. A. Larson, and M. J. Sailor, “Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs,” Molecular Pharmacology, vol. 77, no. 6, pp. 887–894, 2010. View at Publisher · View at Google Scholar · View at PubMed
  31. X. Lin, T. Okuda, A. Holzer, and S. B. Howell, “The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae,” Molecular Pharmacology, vol. 62, no. 5, pp. 1154–1159, 2002. View at Publisher · View at Google Scholar
  32. X. Wu, D. Sinani, H. Kim, and J. Lee, “Copper transport activity of yeast Ctr1 is down-regulated via its C terminus in response to excess copper,” Journal of Biological Chemistry, vol. 284, no. 7, pp. 4112–4122, 2009. View at Publisher · View at Google Scholar · View at PubMed
  33. J. Bertinato, L. Cheung, R. Hoque, and L. J. Plouffe, “Ctr1 transports silver into mammalian cells,” Journal of Trace Elements in Medicine and Biology, vol. 24, no. 3, pp. 178–184, 2010. View at Publisher · View at Google Scholar · View at PubMed
  34. C. A. Larson, P. L. Adams, B. G. Blair, R. Safaei, and S. B. Howell, “The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatin,” Molecular Pharmacology, vol. 78, no. 3, pp. 333–339, 2010. View at Publisher · View at Google Scholar · View at PubMed
  35. Y. Guo, K. Smith, J. Lee, D. J. Thiele, and M. J. Petris, “Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter,” Journal of Biological Chemistry, vol. 279, no. 17, pp. 17428–17433, 2004. View at Publisher · View at Google Scholar · View at PubMed
  36. Z. D. Liang, D. Stockton, N. Savaraj, and M. Tien Kuo, “Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin,” Molecular Pharmacology, vol. 76, no. 4, pp. 843–853, 2009. View at Publisher · View at Google Scholar · View at PubMed
  37. J. F. Eisses and J. H. Kaplan, “Molecular characterization of hCTR1, the human copper uptake protein,” Journal of Biological Chemistry, vol. 277, no. 32, pp. 29162–29171, 2002. View at Google Scholar
  38. S. Puig, J. Lee, M. Lau, and D. J. Thiele, “Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake,” Journal of Biological Chemistry, vol. 277, no. 29, pp. 26021–26030, 2002. View at Publisher · View at Google Scholar · View at PubMed
  39. Z. Wu, Q. Liu, and Q. Liu, “Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1,” Journal of Biological Inorganic Chemistry, vol. 14, no. 8, pp. 1313–1323, 2009. View at Publisher · View at Google Scholar · View at PubMed
  40. C. A. Larson, P. L. Adams, D. D. Jandial, B. G. Blair, R. Safaei, and S. B. Howell, “The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin,” Biochemical Pharmacology, vol. 80, no. 4, pp. 448–454, 2010. View at Publisher · View at Google Scholar · View at PubMed
  41. K. Kampfenkel, S. Kushnir, E. Babiychuk, D. Inze, and M. Van Montagu, “Molecular characterization of a putative Arabidopsis thaliana copper transporter and its yeast homologue,” Journal of Biological Chemistry, vol. 270, no. 47, pp. 28479–28486, 1995. View at Publisher · View at Google Scholar
  42. E. M. Rees and D. J. Thiele, “Identification of a vacuole-associated metalloreductase and its role in Ctr2-mediated intracellular copper mobilization,” Journal of Biological Chemistry, vol. 282, no. 30, pp. 21629–21638, 2007. View at Publisher · View at Google Scholar · View at PubMed
  43. P. V. E. Van Den Berghe, D. E. Folmer, and D. E. Folmer, “Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake,” Biochemical Journal, vol. 407, no. 1, pp. 49–59, 2007. View at Publisher · View at Google Scholar · View at PubMed
  44. J. Bertinato, E. Swist, L. J. Plouffe, S. P. J. Brooks, and M. R. L'Abbé, “Ctr2 is partially localized to the plasma membrane and stimulates copper uptake in COS-7 cells,” Biochemical Journal, vol. 409, no. 3, pp. 731–740, 2008. View at Publisher · View at Google Scholar · View at PubMed
  45. B. G. Blair, C. A. Larson, P. L. Adams, P. B. Abada, R. Safaei, and S. B. Howell, “Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells,” Molecular Pharmacology, vol. 77, no. 6, pp. 912–921, 2010. View at Publisher · View at Google Scholar · View at PubMed
  46. H. J. Liao and G. Carpenter, “Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression,” Molecular Biology of the Cell, vol. 18, no. 3, pp. 1064–1072, 2007. View at Publisher · View at Google Scholar · View at PubMed
  47. J. L. Lee, M. J. Wang, and J. Y. Chen, “Acetylation and activation of STAT3 mediated by nuclear translocation of CD44,” Journal of Cell Biology, vol. 185, no. 6, pp. 949–957, 2009. View at Publisher · View at Google Scholar · View at PubMed
  48. A. K. Holzer, K. Katano, L. W. J. Klomp, and S. B. Howell, “Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells,” Clinical Cancer Research, vol. 10, no. 19, pp. 6744–6749, 2004. View at Publisher · View at Google Scholar · View at PubMed
  49. M. J. Petris, K. Smith, J. Lee, and D. J. Thiele, “Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1,” Journal of Biological Chemistry, vol. 278, no. 11, pp. 9639–9646, 2003. View at Publisher · View at Google Scholar · View at PubMed
  50. D. D. Jandial, S. Farshchi-Heydari, C. A. Larson, G. I. Elliott, W. J. Wrasidlo, and S. B. Howell, “Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1,” Clinical Cancer Research, vol. 15, no. 2, pp. 553–560, 2009. View at Publisher · View at Google Scholar · View at PubMed
  51. M. D. Page, J. Kropat, P. P. Hamel, and S. S. Merchant, “Two Chlamydomonas CTR copper transporters with a novel cys-met motif are localized to the plasma membrane and function in copper assimilation,” Plant Cell, vol. 21, no. 3, pp. 928–943, 2009. View at Publisher · View at Google Scholar · View at PubMed
  52. S. Barhoom, M. Kupiec, X. Zhao, J. R. Xu, and A. Sharon, “Functional characterization of CgCTR2, a putative vacuole copper transporter that is involved in germination and pathogenicity in Colletotrichum gloeosporioides,” Eukaryotic Cell, vol. 7, no. 7, pp. 1098–1108, 2008. View at Publisher · View at Google Scholar · View at PubMed
  53. D. Wang and S. J. Lippard, “Cellular processing of platinum anticancer drugs,” Nature Reviews Drug Discovery, vol. 4, no. 4, pp. 307–320, 2005. View at Publisher · View at Google Scholar · View at PubMed
  54. R. Safaei, S. Otani, B. J. Larson, M. L. Rasmussen, and S. B. Howell, “Transport of cisplatin by the copper efflux transporter ATP7B,” Molecular Pharmacology, vol. 73, no. 2, pp. 461–468, 2008. View at Publisher · View at Google Scholar · View at PubMed
  55. A. K. Holzer, G. Samimi, K. Katano, W. Naerdemann, X. Lin, R. Safaei, and S. B. Howell, “The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells,” Molecular Pharmacology, vol. 66, no. 4, pp. 817–823, 2004. View at Publisher · View at Google Scholar · View at PubMed
  56. J. J. Liu, S. M. F. Jamieson, J. Subramaniam, V. Ip, N. N. Jong, J. F. B. Mercer, and M. J. McKeage, “Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity,” Cancer Chemotherapy and Pharmacology, vol. 64, no. 4, pp. 847–856, 2009. View at Publisher · View at Google Scholar · View at PubMed
  57. N. Pabla, R. F. Murphy, K. Liu, and Z. Dong, “The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity,” American Journal of Physiology, vol. 296, no. 3, pp. F505–F511, 2009. View at Publisher · View at Google Scholar · View at PubMed
  58. J. Zisowsky, S. Koegel, S. Leyers, K. Devarakonda, M. U. Kassack, M. Osmak, and U. Jaehde, “Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells,” Biochemical Pharmacology, vol. 73, no. 2, pp. 298–307, 2007. View at Publisher · View at Google Scholar · View at PubMed
  59. S. B. Howell, R. Safaei, C. A. Larson, and M. J. Sailor, “Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs,” Molecular Pharmacology, vol. 77, no. 6, pp. 887–894, 2010. View at Publisher · View at Google Scholar · View at PubMed
  60. D. Sinani, D. J. Adle, H. Kim, and J. Lee, “Distinct mechanisms for Ctr1-mediated copper and cisplatin transport,” Journal of Biological Chemistry, vol. 282, no. 37, pp. 26775–26785, 2007. View at Publisher · View at Google Scholar · View at PubMed
  61. S. Ishida, F. McCormick, K. Smith-McCune, and D. Hanahan, “Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator,” Cancer Cell, vol. 17, no. 6, pp. 574–583, 2010. View at Publisher · View at Google Scholar · View at PubMed